AstraZeneca started latestage trials on Saturday of an experimental longacting monoclonal antibody combination drug it hopes could be used as a socalled prophylactic to prevent COVID19 infection in atrisk people for up to 12 months.
from Top World News- News18.com https://ift.tt/2UIMELk
Subscribe to:
Post Comments (Atom)
-
The Doha accord would see thousands of American troops quit Afghanistan in a phased plan after more than 18 years in return for various secu...
-
A mysterious dissident group accused of breaking into the North Korea's embassy in Madrid last month said on Thursday it was temporarily...
-
The launch on Monday came two days North Korea's state media said leader Kim Jong Un supervised an artillery drill aimed at testing the ...
No comments:
Post a Comment